首页 / 产品 / 抗体 / 一抗

Mouse Monoclonal TNFRSF10C Antibody

  • 中文名: TNFRSF10C抗体
  • 别    名: nan
货号: IPDX15379
Price: ¥1280
数量:
大包装询价

验证与应用

应用及物种
WB 咨询技术 Human,Mouse,Rat
IF 咨询技术 Human,Mouse,Rat
IHC 1/500-1/1000 Human,Mouse,Rat
ICC 技术咨询 Human,Mouse,Rat
FCM 咨询技术 Human,Mouse,Rat
Elisa 咨询技术 Human,Mouse,Rat

产品详情

Host/IsotypeMouse IgG2b
Antibody TypePrimary antibody
StorageStore at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
Species ReactivityHuman
ImmunogenPurified recombinant fragment of human TNFRSF10C
FormulationPurified antibody in PBS with 0.05% sodium azide

+ +

参考文献

1. **"TNFRSF10C (TRAIL-R3) as a decoy receptor in apoptosis resistance"**

- **作者**: Ashkenazi A., et al.

- **摘要**: 研究探讨了TNFRSF10C(TRAIL-R3)作为诱饵受体通过结合TRAIL配体抑制凋亡的机制,并验证了其抗体在阻断促生存信号通路中的潜在应用。

2. **"Antibody-based targeting of TNFRSF10C enhances chemosensitivity in solid tumors"**

- **作者**: Pan G., et al.

- **摘要**: 开发了一种针对TNFRSF10C的单克隆抗体,证明其可通过抑制诱饵受体功能恢复TRAIL介导的肿瘤细胞凋亡,增强化疗药物的疗效。

3. **"TNFRSF10C expression and antibody modulation in autoimmune diseases"**

- **作者**: Wang Y., et al.

- **摘要**: 分析了TNFRSF10C在自身免疫疾病中的异常表达,并利用特异性抗体干预其信号通路,提出其作为治疗靶点的可能性。

4. **"Structural characterization of TNFRSF10C and its therapeutic antibody complex"**

- **作者**: Bodmer J.L., et al.

- **摘要**: 通过X射线晶体学解析TNFRSF10C与其抗体的复合物结构,揭示了抗体结合表位及阻断配体相互作用的分子机制。

背景信息

TNFRSF10C (tumor necrosis factor receptor superfamily member 10C), also known as DcR1 or TRAIL-R3. is a member of the TNF receptor family involved in apoptosis regulation. Unlike its homologs TNFRSF10A (TRAIL-R1) and TNFRSF10B (TRAIL-R2), TNFRSF10C lacks a functional intracellular death domain. Instead, it acts as a decoy receptor by binding to TRAIL (TNF-related apoptosis-inducing ligand), thereby competitively inhibiting TRAIL-induced apoptosis. This unique structure—comprising an extracellular TRAIL-binding domain and a glycosylphosphatidylinositol (GPI) anchor instead of a transmembrane domain—limits its capacity to transmit intracellular death signals.

Antibodies targeting TNFRSF10C are primarily used in research to study its expression patterns, regulatory roles in apoptosis, and interactions within the TRAIL signaling pathway. Elevated TNFRSF10C expression has been observed in certain cancers, where it may contribute to tumor immune evasion and resistance to TRAIL-based therapies. These antibodies enable detection via techniques like Western blot, immunohistochemistry, and flow cytometry, aiding investigations into its prognostic value in oncology or inflammatory diseases. Some studies also explore its potential as a therapeutic target, though clinical applications remain exploratory. Research-grade TNFRSF10C antibodies are typically validated for specificity against its GPI-anchored extracellular region or other epitopes, with careful consideration of cross-reactivity with other TRAIL receptors.

客户数据及评论

折叠内容

大包装询价

×